The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers
Abstract
We examined a series of 29 surgical specimens of benign and malignant human prostate tissue for the expression of both the cHa‐ras and c‐myc protooncogenes. Northern blots were prepared using polyadenylated mRNA extracted from nine prostatic adenocarcinomas, 19 benign hypertrophied prostates (BPH) and one normal prostate. When the Northern blots were hybridized to a probe for cHa‐ras, only one specimen of BPH showed an appreciable amount of the 1.2‐kb transcript homologous to cHa‐ras. Upon reprobing these blots with c‐myc, six cancers showed a considerable amount of a 2.4‐kb transcript homologous to c‐myc. Three other cancers and all the benign tissue showed little or no detectable 2.4‐kb c‐myc transcript. On retrospective analysis, the cancers with elevated c‐myc transcripts were found to have a Gleason score of 5 and above (poorly differentiated tumors), while the cancers with little or no c‐myc transcripts were all of Gleason score 4 and lower. Finally, we compared our ability to detect c‐myc transcripts in mRNA extracted from a surgically derived prostate tumor with mRNA extracted from the same tumor subject to a sham electrocautery procedure, as would occur during transurethral resection. The electrocautery procedure decreased both the intensity and the integrity of the c‐myc signal in mRNA from the tumor. Thus, our exclusive use of surgically derived prostate tumors may be the reason we are able to detect an elevation in the expression of c‐myc mRNA in high‐grade tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
Balmain, A., Ramsden, M., Bowden, G. T., & Smith, J. (1984) · Nature · doi:10.1038/307658a0 · Cited by 529
Cited by
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Human prostate cancer risk factors
Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S.-M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 650
The Myc oncoprotein as a therapeutic target for human cancer
Vita, M., & Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 552
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Gurel, B., Iwata, T., M Koh, C., Jenkins, R. B., Lan, F., Van Dang, C., Hicks, J. L., Morgan, J., Cornish, T. C., Sutcliffe, S., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.111 · Cited by 441
Neuroendocrine differentiation in prostatic carcinoma
Abrahamsson, P.-A. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990501)39:2<135::aid-pros9>3.0.co;2-s · Cited by 370
Metadata
- Authors
- Buttyan, R., Sawczuk, I. S., Benson, M. C., Siegal, J. D., & Olsson, C. A.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 1987-01
- Volume
- 11
- Issue
- 4
- Pages
- 327-337
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2080891648
- Cited by
- 191
- References
- 1
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers. https://app.cochat.ai/papers/10.1002/pros.2990110405
- The paper
- Buttyan, R., Sawczuk, I. S., Benson, M. C., Siegal, J. D., & Olsson, C. A. (1987). Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers. The Prostate. https://doi.org/10.1002/pros.2990110405
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.